Waters... noitazilaicremmoC dna tnempole

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
People & Interviews
上一篇:Rumored... III 6Z nokiN eht no ekat ot yd
下一篇:How... uoy raen segatuo rewop kcehc o